Eirin’s research provides valuable insights into the economic and health-related impacts of suboptimal medication use among older individuals. Her work highlights the high healthcare costs associated with improper medication practices and evaluates an intervention designed to optimize medication use. While the intervention did not improve health-related quality of life or prove cost-effective across the entire study population, it showed promise in specific subgroups, such as patients without prolonged hospital stays.
Her findings emphasize the need for further research to continue improving medication optimization strategies, particularly for diverse patient populations, including those with prolonged hospitalizations, frailty, or dementia.
We are incredibly proud of Eirin’s hard work and dedication, which contribute significantly to our understanding of medication use in older adults and the pursuit of cost-effective healthcare solutions.
Please join us in congratulating Dr. Eirin Guldsten Robinson on this remarkable achievement!